FDA Pulls Emergency Authorization For Hydroxychloroquine

It's the end of the road for a COVID-19 treatment once heralded as a “game changer” by Trump.

The FDA has revoked its emergency use authorization of hydroxychloroquine and chloroquine.

This is after a review of the evidence showed both drugs are likely ineffective against the virus.

Initially, doctors were allowed to prescribe it for COVID-19 despite it not being approved for that use.

Early studies suggested the drug could affect the coronavirus’s ability to replicate.